Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | ubiquitin-conjugating enzyme subfamily protein | 0.0656 | 0.2953 | 0.5 |
Brugia malayi | ubiquitin conjugating enzyme protein 13 | 0.0656 | 0.2953 | 1 |
Echinococcus granulosus | ubiquitin conjugating enzyme E2 N | 0.0656 | 0.2953 | 1 |
Brugia malayi | Ubiquitin conjugating enzyme protein 13 | 0.0656 | 0.2953 | 1 |
Plasmodium vivax | ubiquitin-conjugating enzyme E2 N, putative | 0.0656 | 0.2953 | 0.5 |
Echinococcus multilocularis | ubiquitin conjugating enzyme E2 N | 0.0656 | 0.2953 | 0.2953 |
Trichomonas vaginalis | Sialidase-1 precursor, putative | 0.0698 | 0.3243 | 1 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0656 | 0.2953 | 0.5 |
Plasmodium falciparum | ubiquitin-conjugating enzyme E2 N, putative | 0.0656 | 0.2953 | 0.5 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0656 | 0.2953 | 0.8434 |
Trypanosoma cruzi | ubiquitin-conjugating enzyme E2, putative | 0.0656 | 0.2953 | 0.5 |
Onchocerca volvulus | 0.0431 | 0.139 | 0.5 | |
Schistosoma mansoni | ubiquitin conjugating enzyme 13 | 0.0656 | 0.2953 | 0.5 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0431 | 0.139 | 0.4708 |
Trichomonas vaginalis | ubiquitin-conjugating enzyme E2, putative | 0.0656 | 0.2953 | 0.8434 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0698 | 0.3243 | 1 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0431 | 0.139 | 0.5 |
Echinococcus granulosus | voltage gated sodium channel Nav1 alpha subunit | 0.0239 | 0.0049 | 0.0165 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0656 | 0.2953 | 1 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0431 | 0.139 | 0.5 |
Loa Loa (eye worm) | ubiquitin conjugating enzyme protein 13 | 0.0656 | 0.2953 | 1 |
Echinococcus multilocularis | sodium channel protein | 0.0239 | 0.0049 | 0.0049 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0431 | 0.139 | 1 |
Entamoeba histolytica | ubiquitin-conjugating enzyme family protein | 0.0656 | 0.2953 | 1 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0431 | 0.139 | 0.4708 |
Echinococcus granulosus | sodium channel protein | 0.0239 | 0.0049 | 0.0165 |
Trypanosoma brucei | ubiquitin-protein ligase, putative | 0.0656 | 0.2953 | 0.5 |
Leishmania major | ubiquitin-conjugating enzyme e2, putative | 0.0656 | 0.2953 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = -8 | Ability to displace [125I]-iodosulpiride from human dopamine D3 (hD3) receptor transfected into CHO cells. | ChEMBL. | 10450981 |
Ki (binding) | = -7.9 | Ability to displace [125I]-iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells. | ChEMBL. | 10450981 |
Log Ki (binding) | = 7.9 | Ability to displace [125I]-iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells. | ChEMBL. | 10450981 |
Log Ki (binding) | = 8 | Ability to displace [125I]-iodosulpiride from human dopamine D3 (hD3) receptor transfected into CHO cells. | ChEMBL. | 10450981 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.